Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CDAX (Performanceindex) | CDAX | Nov 14, 2024 | 1 660.35 | +1.39 |
CDN Maverick Capital Corp | 338B | Nov 14, 2024 | 0.08 | 0.00 |
CDW Corporation | CDW | Nov 14, 2024 | 170.95 | -2.54 |
CECO Environmental Corp. | WCE | Nov 14, 2024 | 23.90 | +2.31 |
Ceconomy AG American Depositary Receipts - Unsponsored | MEOD | Nov 14, 2024 | 0.54 | -0.92 |
Ceconomy AG. | CEC | Nov 14, 2024 | 2.97 | -0.13 |
Cedergrenska | 41C | Nov 14, 2024 | 2.20 | +0.92 |
Cegedim | C7E | Nov 14, 2024 | 10.75 | -0.46 |
Cel-Sci Corp. | LSRM | Nov 14, 2024 | 0.56 | -9.59 |
Celanese Corp | DG3 | Nov 14, 2024 | 70.92 | -2.02 |
Celestica, Inc. | CTW0 | Nov 14, 2024 | 77.00 | -3.14 |
CELL IMPACT AB | ICLA | Nov 14, 2024 | 0.01 | -32.04 |
CellaVision | C26 | Nov 14, 2024 | 20.60 | -0.48 |
Cellcom Israel Limited | F5U | Nov 14, 2024 | 4.18 | 0.00 |
Celldex Therapeutics, Inc. | TCE2 | Nov 14, 2024 | 25.40 | 0.00 |
Cellectar Biosciences | NV4 | Nov 14, 2024 | 1.94 | -3.96 |
Cellectis | ZVA | Nov 14, 2024 | 1.81 | +4.73 |
Cellectis S.A. - American Depositary Shares | ZVAA | Nov 14, 2024 | 1.73 | -1.70 |
CELLINK B | 49Z | Nov 14, 2024 | 3.21 | +0.19 |
Cellnex Telecom S.A. | 472 | Nov 14, 2024 | 31.57 | -2.23 |
Cellnex Telecom SA Unsponsored ADR (Spain) | 4720 | Nov 14, 2024 | 15.20 | 0.00 |
Cellular Goods Plc | 6XS | Nov 14, 2024 | 0.00 | 0.00 |
Celon Pharma SA | 8RP | Nov 14, 2024 | 5.84 | +3.18 |
Celsion Corporation | CBO | Nov 14, 2024 | 0.69 | -2.84 |
Celsius Resources Limited | FX8 | Nov 14, 2024 | 0.01 | -16.67 |
Celtic plc | CCP | Nov 14, 2024 | 1.86 | -7.92 |
Celyad Oncology | 1C0 | Nov 14, 2024 | 0.46 | -11.95 |
Cemat | 1X9 | Nov 14, 2024 | 0.13 | +1.54 |
CEMBRE S.P.A. EO 0,52 | J0L | Nov 14, 2024 | 37.70 | +2.86 |
Cementir Holding N.V. | 3PC | Nov 14, 2024 | 10.32 | +0.98 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.